Fresenius Medical Care AG (FMS) Restructuring Costs (2012 - 2025)

Fresenius Medical Care AG (FMS) has reported Restructuring Costs for 12 consecutive years, with -$138.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Restructuring Costs fell 62.04% year-over-year to -$138.5 million; the TTM figure through Dec 2025 stood at -$153.1 million (down 234.33% YoY), while the FY2025 annual figure was -$138.5 million, down 62.04% from the prior year.
• Restructuring Costs came in at -$138.5 million for Q4 2025 at Fresenius Medical Care AG, down from $85.2 million in the prior quarter.
• The five-year high for Restructuring Costs was $85.2 million in Q1 2025, with the low at -$595.8 million in Q4 2022.
• Average Restructuring Costs over 5 years is -$144.1 million, with a median of -$72.1 million recorded in 2023.
• The largest YoY upside for Restructuring Costs was 460.21% in 2025 against a maximum downside of 62.04% in 2025.
• Year by year, Restructuring Costs stood at -$529.7 million in 2021, then fell by 12.49% to -$595.8 million in 2022, then surged by 87.9% to -$72.1 million in 2023, then slipped by 18.59% to -$85.5 million in 2024, then sank by 62.04% to -$138.5 million in 2025.
• According to Business Quant data, Restructuring Costs over the past three periods registered -$138.5 million, $85.2 million, and -$85.5 million for Q4 2025, Q1 2025, and Q4 2024 respectively.